ACE and metabolic dysfunction-associated steatotic liver disease: Nonalcoholic fatty liver disease is observed with a 5- to 6-fold higher rate in patients with hyperlipidemia compared with the normal population.25 When we compared the two groups in terms of total cholesterol, LDL, VLDL, HDL, TG, a statistically significant difference was found, but no difference was found between the ACE subgroups.